Rotavirus vaccination in developing countries

Tate, 2012, 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis, Lancet Infectious Diseases, 12, 136, 10.1016/S1473-3099(11)70253-5 Tate, 2012, Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality, Expert Review of Vaccines, 11, 211, 10.1586/erv.11.184 Richardson, 2011, Childhood diarrhea deaths after rotavirus vaccination in Mexico, New England Journal of Medicine, 365, 772, 10.1056/NEJMc1100062 Rotavirus vaccines: an update. Weekly Epidemiological Record 2009:533–540. Vesikari, 2006, Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine, New England Journal of Medicine, 354, 23, 10.1056/NEJMoa052664 Ruiz-Palacios, 2006, Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis, New England Journal of Medicine, 354, 11, 10.1056/NEJMoa052434 Phua, 2009, Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomised, double-blind, controlled study, Vaccine, 27, 5936, 10.1016/j.vaccine.2009.07.098 Zaman, 2010, Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial, Lancet, 376, 615, 10.1016/S0140-6736(10)60755-6 Madhi, 2010, Effect of human rotavirus vaccine on severe diarrhea in African infants, New England Journal of Medicine, 362, 289, 10.1056/NEJMoa0904797 Armah, 2010, Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial, Lancet, 376, 606, 10.1016/S0140-6736(10)60889-6 Hanlon, 1987, Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants, Lancet, 1, 1342, 10.1016/S0140-6736(87)90649-0 Patel, 2009, Oral rotavirus vaccines: how well will they work where they are needed most?, Journal of Infectious Diseases, 200, S39, 10.1086/605035 Grassly, 2006, New strategies for the elimination of polio from India, Science, 314, 1150, 10.1126/science.1130388 Desai, 2011, Reduction in morbidity and mortality from childhood diarrhoeal disease after species A rotavirus vaccine introduction in Latin America: a review, Memorias do Instituto Oswaldo Cruz, 106, 907, 10.1590/S0074-02762011000800002 de Palma, 2010, Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study, British Medical Journal, 340, c2825, 10.1136/bmj.c2825 do Carmo, 2011, Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis, PLoS Medicine, 8, e1001024, 10.1371/journal.pmed.1001024 Amador, 2010, Rotavirus disease burden, Nicaragua 2001–2005: defining the potential impact of a rotavirus vaccination program, International Journal of Infectious Diseases, 14, e592, 10.1016/j.ijid.2009.08.014 Wilopo, 2009, Economic evaluation of a routine rotavirus vaccination programme in Indonesia, Vaccine, 27, F67, 10.1016/j.vaccine.2009.09.040 Esposito, 2011, Projected impact and cost-effectiveness of a rotavirus vaccination program in India, 2008, Clinical Infectious Diseases, 52, 171, 10.1093/cid/ciq094 Rose, 2009, Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis, British Medical Journal, 339, b3653, 10.1136/bmj.b3653 Khoury, 2011, Burden of rotavirus gastroenteritis in the Middle Eastern and North African pediatric population, BMC Infectious Diseases, 11, 9, 10.1186/1471-2334-11-9 Berry, 2010, The cost-effectiveness of rotavirus vaccination in Malawi, Journal of Infectious Diseases, 202, S108, 10.1086/653578 Arvay, 2009, How much could rotavirus vaccines reduce diarrhea-associated mortality in northern Ghana? A model to assess impact, Journal of Infectious Diseases, 200, S85, 10.1086/605062 Tate, 2011, Projected health benefits and costs of pneumococcal and rotavirus vaccination in Uganda, Vaccine, 29, 3329, 10.1016/j.vaccine.2010.12.122 Tate, 2009, Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in kenya, Journal of Infectious Diseases, 200, S76, 10.1086/605058 Tate, 2009, Disease and economic burden of rotavirus diarrhoea in India, Vaccine, 27, F18, 10.1016/j.vaccine.2009.08.098 Mendelsohn, 2008, Estimates of the economic burden of rotavirus-associated and all-cause diarrhoea in Vellore, India, Tropical Medicine and International Health, 13, 934, 10.1111/j.1365-3156.2008.02094.x Simpson, 2007, Use of formative research in developing a knowledge translation approach to rotavirus vaccine introduction in developing countries, BMC Public Health, 7, 281, 10.1186/1471-2458-7-281 Murphy, 2001, Intussusception among infants given an oral rotavirus vaccine, New England Journal of Medicine, 344, 564, 10.1056/NEJM200102223440804 Shui, 2012, Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants, The Journal of the American Medical Association, 307, 598, 10.1001/jama.2012.97 Buttery, 2011, Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia, Vaccine, 29, 3061, 10.1016/j.vaccine.2011.01.088 Patel, 2011, Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil, New England Journal of Medicine, 364, 2283, 10.1056/NEJMoa1012952 Ustrup, 2011, Outstanding challenges for rotavirus vaccine introduction in low-income countries – a systematic review, Danish Medical Bulletin, 58, A4323 Sinclair, 2011, Oral vaccines for preventing cholera, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD008603.pub2 Okayasu, 2011, Mucosal immunity and poliovirus vaccines: impact on wild poliovirus infection and transmission, Vaccine, 29, 8205, 10.1016/j.vaccine.2011.08.059 Serazin, 2010, Improving the performance of enteric vaccines in the developing world, Nature Immunology, 11, 769, 10.1038/ni0910-769 Kim, 2011, Sidestepping maternal antibody: a lesson from measles virus vaccination, Expert Review of Clinical Immunology, 7, 557, 10.1586/eci.11.48 Brandtzaeg, 2010, Function of mucosa-associated lymphoid tissue in antibody formation, Immunological Investigations, 39, 303, 10.3109/08820131003680369 Salzman, 2007, Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa, Seminars in Immunology, 19, 70, 10.1016/j.smim.2007.04.002 Thomas, 2012, New insights into the impact of the intestinal microbiota on health and disease: a symposium report, British Journal of Nutrition, 107, S1, 10.1017/S0007114511006970 Steele, 2009, Rotavirus vaccines for infants in developing countries in Africa and Asia: considerations from a world health organization-sponsored consultation, Journal of Infectious Diseases, 200, S63, 10.1086/605042 Bhandari, 2006, Safety and immunogenicity of two live attenuated human rotavirus vaccine candidates, 116E and I321, in infants: results of a randomised controlled trial, Vaccine, 24, 5817, 10.1016/j.vaccine.2006.05.001 Bresee, 2005, Update on rotavirus vaccines, Pediatric Infectious Disease Journal, 24, 947, 10.1097/01.inf.0000186295.18969.e6 Bhaskaram, 1997, Systemic and mucosal immune response to polio vaccination with additional dose in newborn period, Journal of Tropical Pediatrics, 43, 232, 10.1093/tropej/43.4.232 Albert, 2003, Supplementation with zinc, but not vitamin A, improves seroconversion to vibriocidal antibody in children given an oral cholera vaccine, Journal of Infectious Diseases, 187, 909, 10.1086/368132 Gladstone, 2011, Protective effect of natural rotavirus infection in an Indian birth cohort, New England Journal of Medicine, 365, 337, 10.1056/NEJMoa1006261 Kang, 2009, Multicenter, hospital-based surveillance of rotavirus disease and strains among indian children aged <5 years, Journal of Infectious Diseases, 200, S147, 10.1086/605031 Gill, 1983, Transplacental immunization of the human fetus to tetanus by immunization of the mother, Journal of Clinical Investigation, 72, 987, 10.1172/JCI111071 Snodgrass, 1980, Passive immunity in calf rotavirus infections: maternal vaccination increases and prolongs immunoglobulin G1 antibody secretion in milk, Infection and Immunity, 28, 344, 10.1128/iai.28.2.344-349.1980 Zhou, 2011, Prime immunization with rotavirus VLP 2/6 followed by boosting with an adenovirus expressing VP6 induces protective immunization against rotavirus in mice, Virology Journal, 8, 3, 10.1186/1743-422X-8-3 Franco, 2006, Immunity and correlates of protection for rotavirus vaccines, Vaccine, 24, 2718, 10.1016/j.vaccine.2005.12.048 Desselberger, 2011, Immune responses to rotavirus infection and vaccination and associated correlates of protection, Journal of Infectious Diseases, 203, 188, 10.1093/infdis/jiq031 McNeal, 1994, Active immunity against rotavirus infection in mice is correlated with viral replication and titers of serum rotavirus IgA following vaccination, Virology, 204, 642, 10.1006/viro.1994.1579 Crawford, 1999, Heterotypic protection and induction of a broad heterotypic neutralization response by rotavirus-like particles, Journal of Virology, 73, 4813, 10.1128/JVI.73.6.4813-4822.1999 Jiang, 1999, Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles, Vaccine, 17, 1005, 10.1016/S0264-410X(98)00317-X